Associate Professor Ruth Colagiuri, founder of the Juvenile Arthritis Foundation Australia, whose grandchild lives with arthritis, told BioPharmaDispatch that the announcement was excellent news for the community because it an important treatment option affordable for more families.
'Juvenile arthritis is one of the most under-recognised, misunderstood, and neglected childhood
December 11, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News -
Young NZ cancer patients to get funded medicines no matter where they are treated
October 6, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
CSL announces investment for share of Alentis rare kidney and liver candidate
October 6, 2026 - - Latest News -
TGA approves Roche's refillable eye implant for wet macular degeneration
October 5, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
October 2, 2026 - - Podcast -
Under the TGA's new rules, the safest story is one without the patient experience
October 2, 2026 - - Latest News
